Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: May 2026.
- Largest single sale: $1.6M (6,907 shares) of Jazz Pharmaceuticals plc on May 28, 2026. Filing
- Last sale before this period: Feb 2, 2023.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | EVP, Chief Commercial Officer | May 11, 2020 | Aug 7, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 5, 2026, Jazz Pharmaceuticals plc: 780 shares withheld by the company for taxes. 1 filing: 1
- Jun 30, 2026, Jazz Pharmaceuticals plc: 2,527 shares withheld by the company for taxes. 1 filing: 1
- May 28, 2026, Jazz Pharmaceuticals plc: sold 6,907 shares for $1.6M, no plan disclosed; 6,907 shares acquired by exercising options. 1 filing: 1
- Mar 5, 2026, Jazz Pharmaceuticals plc: 2,503 shares withheld by the company for taxes. 1 filing: 1
- Feb 26, 2026, Jazz Pharmaceuticals plc: 9,782 shares granted. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.